Pui San Tan
Cited by
Cited by
Meta-analysis of first-line therapies in advanced non–small-cell lung cancer harboring EGFR-activating mutations
B Haaland, P San Tan, G de Castro Jr, G Lopes
Journal of Thoracic Oncology 9 (6), 805, 2014
Clinician-targeted interventions to influence antibiotic prescribing behaviour for acute respiratory infections in primary care: an overview of systematic reviews.
CBDM SK Tonkin-Crine, PS Tan, O van Hecke, K Wang, NW Roberts, A McCullough ...
The Cochrane database of systematic reviews 9, CD012252, 2017
The challenge of antimicrobial resistance: what economics can contribute
LSJ Roope, RD Smith, KB Pouwels, J Buchanan, L Abel, P Eibich, ...
Science 364 (6435), 2019
Cost-effectiveness of Osimertinib in the first-line treatment of patients with EGFR-Mutated advanced non–Small cell lung Cancer
PN Aguiar, B Haaland, W Park, P San Tan, A del Giglio, G de Lima Lopes
JAMA oncology 4 (8), 1080-1084, 2018
Ten-year survival in women with primary stage IV breast cancer
LG Eng, S Dawood, V Sopik, B Haaland, P San Tan, N Bhoo-Pathy, ...
Breast cancer research and treatment 160 (1), 145-152, 2016
Comparative effectiveness of immune-checkpoint inhibitors for previously treated advanced non-small cell lung cancer–A systematic review and network meta-analysis of 3024 …
P San Tan, P Aguiar Jr, B Haaland, G Lopes
Lung Cancer 115, 84-88, 2018
Hormonal Therapeutics Enzalutamide and Abiraterone Acetate in the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Post-docetaxel—an Indirect Comparison
PS Tan, B Haaland, AJ Montero, CE Kyriakopoulos, G Lopes
Clinical Medicine Insights: Oncology 8, CMO. S13671, 2014
A meta-analysis of anastrozole in combination with fulvestrant in the first line treatment of hormone receptor positive advanced breast cancer
P San Tan, B Haaland, AJ Montero, G Lopes
Breast cancer research and treatment 138 (3), 961-965, 2013
The clinical utility of point-of-care tests for influenza in ambulatory care: A systematic review and meta-analysis
JJ Lee, JY Verbakel, CR Goyder, T Ananthakumar, PS Tan, PJ Turner, ...
Clinical Infectious Diseases 69 (1), 24-33, 2019
Overview of systematic reviews assessing the evidence for shorter versus longer duration antibiotic treatment for bacterial infections in secondary care
IJ Onakpoya, AS Walker, PS Tan, EA Spencer, OA Gbinigie, J Cook, ...
PloS one 13 (3), e0194858, 2018
Childhood drowning in Malaysia
AS Hss, PS Tan, L Hashim
International journal of injury control and safety promotion 21 (1), 75-80, 2014
Impact of point-of-care C reactive protein in ambulatory care: a systematic review and meta-analysis
JY Verbakel, JJ Lee, C Goyder, P San Tan, T Ananthakumar, PJ Turner, ...
BMJ open 9 (1), e025036, 2019
Meta‐analysis of first‐line therapies with maintenance regimens for advanced non‐small‐cell lung cancer (NSCLC) in molecularly and clinically selected populations
PS Tan, M Bilger, G de Lima Lopes, S Acharyya, B Haaland
Cancer medicine 6 (8), 1847-1860, 2017
Addition of abiraterone, docetaxel, bisphosphonate, celecoxib or combinations to androgen-deprivation therapy (ADT) for metastatic hormone-sensitive prostate cancer (mHSPC): a …
P San Tan, P Aguiar, B Haaland, G Lopes
Prostate cancer and prostatic diseases 21 (4), 516-523, 2018
Bayesian network meta-comparison of maintenance treatments for stage IIIb/IV non-small-cell lung cancer (NSCLC) patients with good performance status not progressing after …
P San Tan, G Lopes, S Acharyya, M Bilger, B Haaland
European Journal of Cancer 51 (16), 2330-2344, 2015
A systematic review and meta-analyses of the association between anti-hypertensive classes and the risk of falls among older adults
HT Ang, KK Lim, YH Kwan, P San Tan, KZ Yap, Z Banu, CS Tan, W Fong, ...
Drugs & aging 35 (7), 625-635, 2018
Cost-effectiveness analysis of abiraterone, docetaxel or placebo plus androgen deprivation therapy for hormone-sensitive advanced prostate cancer
PN Aguiar Jr, P San Tan, S Simko, CMN Barreto, B de Souza Gutierres, ...
Einstein 17 (2), 2019
Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people
J Hippisley-Cox, D Young, C Coupland, KM Channon, P San Tan, ...
Heart 106 (19), 1503-1511, 2020
Anastrozole in combination with fulvestrant in the first line treatment of hormone receptor positive advanced breast cancer: A meta-analysis.
PS Tan, B Haaland, AJ Montero, G Lopes
Indirect Comparison between Immune-Checkpoint Inhibitors for 2nd Line Non-Small Cell Lung Cancer-a Network Meta-Analysis
P Tan, P Aguiar Jr, B Haaland, G Lopes
JOURNAL OF THORACIC ONCOLOGY 12 (11), S2149-S2149, 2017
The system can't perform the operation now. Try again later.
Articles 1–20